Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | GMAB | ASND | ||
| Company | Intra-Cellular Ther | Genmab A/S ADR | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 25.88 | 222.87 | ||
| High | 131.98 | 26.35 | 237.81 | ||
| Low | 131.63 | 25.87 | 217.52 | ||
| Latest | 131.87 | 26.03 | 220.60 | ||
| Change | -0.05 | -0.08 | -0.30 | ||
| % Change | -0.04% | -0.31% | -0.14% | ||
| Volume | 16,062,900 | 3,059,900 | 388,100 | ||
| 20-Day Average Volume | 2,474,570 | 1,681,310 | 596,385 | ||
| Previous Close | 131.92 | 26.11 | 220.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 26.90 | 230.22 | ||
| 20-Day Raw Stochastic | 86.25% | 22.02% | 22.23% | ||
| 20-Day Relative Strength | 82.75 | 37.46 | 46.30 | ||
| Weighted Alpha | +83.21 | +17.76 | +37.98 | ||
| Today's Opinion | 100% Buy | 72% Sell | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +1.17% since 03/19/26 | -1.44% since 03/19/26 | ||
| Low | 131.63 on 04/01/25 | 24.95 on 03/20/26 | 212.60 on 03/24/26 | ||
| High | 131.98 on 04/01/25 | 26.36 on 03/25/26 | 237.81 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | -10.98% since 02/26/26 | -3.66% since 02/26/26 | ||
| Low | 131.18 on 03/05/25 | 24.95 on 03/20/26 | 212.60 on 03/24/26 | ||
| High | 131.98 on 04/01/25 | 29.85 on 03/02/26 | 248.60 on 03/03/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | -22.11% since 12/26/25 | +5.56% since 12/26/25 | ||
| Low | 80.82 on 01/07/25 | 24.95 on 03/20/26 | 188.08 on 01/12/26 | ||
| High | 131.98 on 04/01/25 | 35.43 on 01/14/26 | 248.60 on 03/03/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | -10.46% since 09/26/25 | +14.90% since 09/26/25 | ||
| Low | 70.90 on 10/07/24 | 24.95 on 03/20/26 | 186.05 on 10/20/25 | ||
| High | 131.98 on 04/01/25 | 35.43 on 01/14/26 | 248.60 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 16,775,859 | 13,690,719 | ||
| Shares Outstanding, K | 106,522 | 642,507 | 61,977 | ||
| Annual Sales | 680,850,000 | 3,720,000,000 | 814,760,000 | ||
| Annual Net Income | -74,680,000 | 963,000,000 | -258,000,000 | ||
| Last Quarter Sales | 199,220,000 | 1,058,000,000 | 279,270,000 | ||
| Last Quarter Net Income | -16,890,000 | 31,000,000 | -42,910,000 | ||
| 60-Month Beta | 0.46 | 0.94 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 0.05 on 02/17/26 | -0.64 on 02/11/26 | ||
| Latest Earnings Date | 05/06/25 | 05/14/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.65 | 0.00 | ||